Literature DB >> 20160186

Anticoagulant therapy for percutaneous coronary intervention.

Sunil V Rao1, E Magnus Ohman.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 20160186     DOI: 10.1161/CIRCINTERVENTIONS.109.884478

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN: 1941-7640            Impact factor:   6.546


× No keyword cloud information.
  21 in total

Review 1.  Which antithrombin for whom? Identifying the patient population that benefits most from novel antithrombin agents.

Authors:  David A Burke; Haider J Warraich; Duane S Pinto
Journal:  Curr Cardiol Rep       Date:  2012-08       Impact factor: 2.931

Review 2.  Proteins interacting with the 26S proteasome.

Authors:  R Hartmann-Petersen; C Gordon
Journal:  Cell Mol Life Sci       Date:  2004-07       Impact factor: 9.261

3.  Atrial fibrillation and percutaneous coronary intervention: stroke, thrombosis, and bleeding.

Authors:  Antonio Gutierrez; Sunil V Rao
Journal:  Curr Treat Options Cardiovasc Med       Date:  2011-06

4.  Association between periprocedural bleeding and long-term outcomes following percutaneous coronary intervention in older patients.

Authors:  Sunil V Rao; David Dai; Sumeet Subherwal; William S Weintraub; Ralph S Brindis; John C Messenger; Renato D Lopes; Eric D Peterson
Journal:  JACC Cardiovasc Interv       Date:  2012-09       Impact factor: 11.195

5.  Association of Physician Certification in Interventional Cardiology With In-Hospital Outcomes of Percutaneous Coronary Intervention.

Authors:  Paul N Fiorilli; Karl E Minges; Jeph Herrin; John C Messenger; Henry H Ting; Brahmajee K Nallamothu; Rebecca S Lipner; Brian J Hess; Eric S Holmboe; Joseph J Brennan; Jeptha P Curtis
Journal:  Circulation       Date:  2015-09-18       Impact factor: 29.690

6.  [Antiplatelet therapy and anticoagulation in acute coronary syndrome: current evidence].

Authors:  S de Waha; H Thiele; G Richardt
Journal:  Herz       Date:  2014-09       Impact factor: 1.443

7.  Bivalirudin as a Systemic Anticoagulant and Flush Solution Additive for Sequential Mitral and Tricuspid Valve Percutaneous Edge-to-Edge Repair in a Patient With Heparin-Induced Thrombocytopenia.

Authors:  Zachary Colbaugh; Thomas Evans Watts; Mustafa I Ahmed; Dylan R Addis
Journal:  J Cardiothorac Vasc Anesth       Date:  2021-03-06       Impact factor: 2.894

8.  Precision medicine to improve use of bleeding avoidance strategies and reduce bleeding in patients undergoing percutaneous coronary intervention: prospective cohort study before and after implementation of personalized bleeding risks.

Authors:  John A Spertus; Carole Decker; Elizabeth Gialde; Philip G Jones; Edward J McNulty; Richard Bach; Adnan K Chhatriwalla
Journal:  BMJ       Date:  2015-03-24

Review 9.  An overview of PCI in the very elderly.

Authors:  Vimalraj Bogana Shanmugam; Richard Harper; Ian Meredith; Yuvaraj Malaiapan; Peter J Psaltis
Journal:  J Geriatr Cardiol       Date:  2015-03       Impact factor: 3.327

Review 10.  Direct-Acting Oral Anticoagulants: Practical Considerations for Emergency Medicine Physicians.

Authors:  W Frank Peacock; Zubaid Rafique; Adam J Singer
Journal:  Emerg Med Int       Date:  2016-05-16       Impact factor: 1.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.